Globus Medical, Inc. (GMED)

Globus Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	356.65	102.98	122.87	190.17	149.19	102.29
Depreciation & Amortization	271.64	254.02	144.73	68.25	69.87	62.87
Loss (Gain) From Sale of Assets	11.22	5.55	1.54	0.3	0.46	0.81
Asset Writedown & Restructuring Costs	-	12.61	-	0.15	34.31	24.42
Loss (Gain) From Sale of Investments	-1.04	-0.64	0.79	5.39	2.78	0.59
Stock-Based Compensation	50.94	54.19	52.74	32.81	30.59	27.07
Provision & Write-off of Bad Debts	10.06	16.99	3.66	-0	1.2	2.96
Other Operating Activities	-45.41	172.48	33.76	-13.34	5.13	15.38
Change in Accounts Receivable	66.54	-78.06	-49.91	-50.84	-25.9	10.7
Change in Inventory	-18.73	-29.86	-70.33	-61.75	-11.97	-50.11
Change in Accounts Payable	2.02	17.66	-14.22	14.42	3.68	-6.35
Change in Income Taxes	-58.78	-13.38	-0.41	-2.89	5.21	1.66
Change in Other Net Operating Assets	24.05	6.08	18.28	-4.21	11.72	6.52
Operating Cash Flow	669.16	520.64	243.5	178.47	276.27	198.79
Operating Cash Flow Growth	155.60%	113.81%	36.44%	-35.40%	38.98%	15.59%
Capital Expenditures	-141.73	-115.43	-78.27	-74.05	-56.9	-63.66
Cash Acquisitions	-252.65	-17.64	-296.03	-31.44	-34.49	-33.48
Investment in Securities	112.56	-42.99	677.27	-4.88	-284.55	-20.18
Investing Cash Flow	-286.81	-176.05	302.97	-110.36	-375.94	-117.32
Issuance of Common Stock	108.71	110.44	12.4	41.72	63.5	72.32
Repurchase of Common Stock	-220.18	-92.52	-236.18	-144.49	-	-104.67
Other Financing Activities	-19.56	-45.62	-8.04	-7.19	-9.35	-6.32
Financing Cash Flow	-581.02	-27.7	-231.82	-109.96	54.15	-38.66
Foreign Exchange Rate Adjustments	17.69	0.26	2.18	-0.75	-0.81	0.87
Net Cash Flow	-180.98	317.15	316.83	-42.6	-46.33	43.67
Free Cash Flow	527.43	405.21	165.23	104.42	219.38	135.14
Free Cash Flow Growth	227.55%	145.25%	58.23%	-52.40%	62.34%	33.50%
Free Cash Flow Margin	20.08%	16.08%	10.53%	10.21%	22.90%	17.13%
Free Cash Flow Per Share	3.81	2.94	1.44	1.02	2.12	1.34
Cash Income Tax Paid	180.15	158.51	100.59	77.82	45.03	25.44
Levered Free Cash Flow	456.11	598.37	-346.92	75.52	160.53	88.28
Unlevered Free Cash Flow	456.11	600.98	-346.92	75.52	160.53	88.28
Change in Working Capital	15.09	-97.55	-116.6	-105.26	-17.25	-37.59

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q